Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis

NICE

2 November 2022 - NICE is unable to make a recommendation on slow-release potassium bicarbonate–potassium citrate (Sibnayal) for treating distal renal tubular acidosis in people 1 year and over.

This is because Advicenne withdrew its evidence submission. NICE will review this decision if Advicenne decides to make a submission.

Read NICE technology appraisal

Michael Wonder

Posted by:

Michael Wonder